BridgeBio Oncology Therap... (BBOT)
NASDAQ: BBOT
· Real-Time Price · USD
12.36
-0.08 (-0.64%)
At close: Oct 03, 2025, 3:59 PM
12.60
1.94%
After-hours: Oct 03, 2025, 07:57 PM EDT
-0.64% (1D)
| Bid | 11.47 |
| Market Cap | 978.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 4.72M |
| EPS (ttm) | -1.14 |
| PE Ratio (ttm) | -10.84 |
| Forward PE | -5.53 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 12.51 |
| Volume | 115,597 |
| Avg. Volume (20D) | 220,626 |
| Open | 12.99 |
| Previous Close | 12.44 |
| Day's Range | 12.13 - 12.99 |
| 52-Week Range | 8.50 - 13.04 |
| Beta | 0.08 |
| Ex-Dividend Date | n/a |
About BBOT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBOT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BBOT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+8.01%
BridgeBio Oncology Therapeutics shares are trading...
Unlock content with
Pro Subscription
1 month ago
+13.43%
BridgeBio Oncology Therapeutics shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $25.